2008•Unpublished venueRequires access

SIMULTANEOUS DETERMINATION OF RABEPRAZOLE AND DOMPERIDONE IN DOSAGE FORMS BY RP-HPLC

Kalirajan Rajagopal, Kalirajan Rajagopal, Seena Mary Mathew, Gowramma Byran, Jubie Selvaraj, B Suresh

Open publisher page 6 citations

Abstract

A rapid and accurate high performance reverse phase liquid chromatography has been developed for the simultaneous determination of rabeprazole and domperidone in pharmaceutical dosage forms. Chromatography was carried out on a C-18 column (4.6 mm × 250 mm, 5 μm) using a mixture of phosphate buffer (pH 7.4) and acetonitrile in the ratio of 65:35 (v/v) as the mobile phase at a flow rate of 1.5 mL/min and eluents are monitored at 290nm. The calibration curves were linear over the range of 0.1 – 1.0 mg/mL of rabeprazole. The average retention time of rabeprazole and domperidone was found to be 5.45 and 11.07 respectively. The % recovery value for rabeprazole is 100.2% and for domperidone is 102% confirms the non-interferences of the excipients in the formulation. Due to its simplicity, rapidness and high precision, the proposed HPLC method may be used for the simultaneous determination of these two drugs in pharmaceutical dosage forms.

About this research paper

What this paper is about

A rapid and accurate high performance reverse phase liquid chromatography has been developed for the simultaneous determination of rabeprazole and domperidone in pharmaceutical dosage forms. Chromatography was carried out on a C-18 column (4.6 mm × 250 mm, 5 μm) using a mixture of phosphate buffer (pH 7.4) and acetonitrile in the ratio of 65:35 (v/v) as the mobile phase at a flow rate of 1.5 mL/min and eluents are monitored at 290nm. The calibration curves were linear over the range of 0.1 – 1.0 mg/mL of rabeprazole. The average retention time of rabeprazole and domperidone was found to be 5.45 and 11.07 respectively. The % recovery value for rabeprazole is 100.2% and for domperidone is 102% confirms the non-interferences of the excipients in the formulation. Due to its simplicity, rapidness and high precision, the proposed HPLC method may be used for the simultaneous determination of these two drugs in pharmaceutical dosage forms.

Why it matters

OpenAlex reports 6 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

A rapid and accurate high performance reverse phase liquid chromatography has been developed for the simultaneous determination of rabeprazole and domperidone in pharmaceutical dosage forms. Chromatography was carried out on a C-18 column (4.6 mm × 250 mm, 5 μm) using a mixture of phosphate buffer (pH 7.4) and acetonitrile in the ratio of 65:35 (v/v) as the mobile phase at a flow rate of 1.5 mL/min and eluents are monitored at 290nm. The calibration curves were linear over the range of 0.1 – 1.0 mg/mL of rabeprazole. The average retention time of rabeprazole and domperidone was found to be 5.45 and 11.07 respectively. The % recovery value for rabeprazole is 100.2% and for domperidone is 102% confirms the non-interferences of the excipients in the formulation. Due to its simplicity, rapidness and high precision, the proposed HPLC method may be used for the simultaneous determination of these two drugs in pharmaceutical dosage forms.

Key concepts: Domperidone, Rabeprazole, Chromatography, Dosage form, Chemistry, High-performance liquid chromatography, Acetonitrile, Reproducibility

Related papers

Back to paper searchBrowse research topicsOriginal source
SIMULTANEOUS DETERMINATION OF RABEPRAZOLE AND DOMPERIDONE IN DOSAGE FORMS BY RP-HPLC — Research Paper | ScholarLens